Puma Biotechnology IncPuma Biotechnology IncPuma Biotechnology Inc

Puma Biotechnology Inc

No trades
See on Supercharts
Market capitalization
‪254.05 M‬USD
‪21.59 M‬USD
‪235.64 M‬USD
‪34.68 M‬
Beta (1Y)
1.64

About Puma Biotechnology Inc

CEO
Alan H. Auerbach
Headquarters
Los Angeles
Employees (FY)
185
Founded
2010
ISIN
US74587V1070
FIGI
BBG0018YXYX7
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PBYI is 5.30 USD — it has decreased by 1.03% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Puma Biotechnology Inc stocks are traded under the ticker PBYI.
Puma Biotechnology Inc is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Puma Biotechnology Inc has a max estimate of 7.00 USD and a min estimate of 2.00 USD.
PBYI earnings for the last quarter are 0.12 USD whereas the estimation was 0.08 USD which accounts for 56.52% surprise. Estimated earnings for the next quarter are 0.30 USD. See more details about Puma Biotechnology Inc earnings.
Puma Biotechnology Inc revenue for the last quarter amounts to ‪56.10 M‬ USD despite the estimated figure of ‪57.95 M‬ USD. In the next quarter revenue is expected to reach ‪73.55 M‬ USD.
Yes, you can track Puma Biotechnology Inc financials in yearly and quarterly reports right on TradingView.
Like other stocks, PBYI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Puma Biotechnology Inc stock right from TradingView charts — choose your broker and connect to your account.
PBYI reached its all-time high on Aug 26, 2014 with the price of 279.37 USD, and its all-time low was 1.60 USD and was reached on May 11, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 185.00 employees. See our rating of the largest employees — is Puma Biotechnology Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Puma Biotechnology Inc EBITDA is ‪44.78 M‬ USD, and current EBITDA margin is 19.01%. See more stats in Puma Biotechnology Inc financial statements.